Medicare Enrolled
Dr. Elisa Yoo, M.D.
MOHS-Micrographic Surgery Physician · Los Alamitos, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Yoo from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Yoo?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Yoo
Dr. Elisa Yoo is a mohs-micrographic surgery physician in Los Alamitos, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Yoo performed 3,929 Medicare services across 2,488 unique beneficiaries.
Between the years covered by Open Payments, Dr. Yoo received a total of $7,154 from 43 pharmaceutical and/or device companies across 263 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in mohs-micrographic surgery physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Yoo is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 43% volume in CA
$7,154 industry payments
Medicare Practice Summary
Medicare Utilization ↗3,929
Medicare services
Top 43% in CA for mohs-micrographic surgery physician
2,488
Unique beneficiaries
$117
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~207 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
874 | $77 | $245 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
513 | $108 | $358 |
| Destruction of 15 or more precancerous skin growths This procedure involves the removal or destruction of fifteen or more precancerous skin lesions. It is performed to treat abnormal skin cells that have the potential to develop into cancer. |
316 | $154 | $584 |
| Destruction of skin growths (warts/lesions), 1-14 This procedure involves the removal or destruction of one to fourteen skin growths. It is a minor surgical intervention performed on the skin surface. |
302 | $105 | $401 |
| Destruction of precancerous skin growths, 2-14 This procedure involves the removal or destruction of two to fourteen precancerous skin lesions. It is performed to eliminate abnormal skin cells that have the potential to develop into cancer. |
293 | $6 | $23 |
| Skin biopsy, tangential A procedure to remove a sample of the first identified skin growth for laboratory examination. |
273 | $92 | $428 |
| Puraply AM application per square centimeter Application of Puraply AM dressing to the skin. The charge is calculated based on the surface area treated. |
239 | $82 | $501 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
136 | $50 | $150 |
| Additional skin growth biopsy Removal of a sample of an additional skin growth for laboratory examination. This code is used for each extra lesion biopsied during the same session. |
125 | $46 | $231 |
| Destruction of precancerous skin growth, 1 Removal of a single precancerous skin growth. This procedure destroys abnormal skin cells to prevent them from developing into cancer. |
121 | $46 | $289 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
120 | $144 | $546 |
| Punch biopsy of first skin growth A small, circular piece of skin is removed from a skin growth using a circular blade. The sample is then sent to a laboratory for examination. |
117 | $114 | $539 |
| Topical aminolevulinic acid HCl 20% solution A topical medication applied to the skin for medical treatment. It is supplied as a single-unit dosage form containing 354 mg of the active ingredient. |
84 | $307 | $1,010 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
80 | $96 | $362 |
| Skin growth removal and lab exam, 1-5 blocks This procedure involves the removal of a growth from the head, neck, hands, feet, or genitals. The removed tissue is then examined under a microscope in the laboratory. |
69 | $601 | $2,270 |
| Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks | 64 | $366 | $1,370 |
| Light application with debridement to destroy precancerous skin growth This procedure involves applying light to the skin along with debridement to destroy precancerous skin growths. |
54 | $267 | $600 |
| Skin graft repair, 30.1-60.0 sq cm A surgical procedure to repair a wound by transferring skin from one area to another. This code applies to grafts covering an area between 30.1 and 60.0 square centimeters. |
32 | $971 | $3,670 |
| Punch biopsy of additional skin growth A small circular tool is used to remove a sample of an extra skin growth for laboratory examination. |
29 | $55 | $264 |
| Intermediate wound repair, 2.6-7.5 cm A medical procedure to close a wound on the scalp, underarms, trunk, arms, or legs that measures between 2.6 and 7.5 centimeters. This type of repair involves cleaning the wound and stitching it closed to promote healing. |
23 | $263 | $1,074 |
| Destruction of cancerous skin growth, 2.1-3.0 cm This procedure involves the removal or destruction of a cancerous skin lesion measuring between 2.1 and 3.0 centimeters located on the trunk, arms, or legs. |
23 | $177 | $667 |
| Skin substitute graft application, 25 sq cm or less Application of a skin substitute graft to a wound on the face, scalp, eyelids, mouth, neck, ears, around eyes, genitals, hands, feet, fingers, or toes. The wound area covered is 25.0 square centimeters or less. |
14 | $97 | $728 |
| Destruction of cancer skin growth, 1.1-2.0 cm Removal of a cancerous skin growth on the trunk, arms, or legs that measures between 1.1 and 2.0 centimeters. |
14 | $158 | $612 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
14 | $80 | $245 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$7,154
Total received (2018-2024)
Avg $1,022/year across 7 years
Top 23% in CA for mohs-micrographic surgery physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
43
Companies
263
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,006 (97.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$149 (2.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,211
2023
$890
2022
$1,241
2021
$767
2020
$637
2019
$1,140
2018
$1,268
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$415
E.R. Squibb & Sons, L.L.C.
$183
ABBVIE INC.
$91
GENZYME CORPORATION
$77
Janssen Biotech, Inc.
$68
Dermavant Sciences, Inc.
$62
Lilly USA, LLC
$58
AstraZeneca Pharmaceuticals LP
$44
LEO Pharma Inc.
$35
SUN PHARMACEUTICAL INDUSTRIES INC.
$35
Almirall LLC
$30
Novartis Pharmaceuticals Corporation
$27
Neurent Medical Limited
$23
Integra LifeSciences Corporation
$22
Regeneron Healthcare Solutions, Inc.
$22
Incyte Corporation
$19
Top 3 companies account for 57.0% of 2024 payments
All-time payments by company (2018-2024) ›
Stryker Corporation
$1,292
Amgen Inc.
$675
PFIZER INC.
$606
GENZYME CORPORATION
$437
Janssen Biotech, Inc.
$421
Lilly USA, LLC
$364
Novartis Pharmaceuticals Corporation
$349
Regeneron Healthcare Solutions, Inc.
$279
AbbVie, Inc.
$243
Incyte Corporation
$217
LEO Pharma Inc.
$208
E.R. Squibb & Sons, L.L.C.
$183
ABBVIE INC.
$183
Medtronic, Inc.
$156
Ortho Dermatologics, a division of Bausch Health US, LLC
$146
Sun Pharmaceutical Industries Inc.
$133
Optinose US, Inc.
$118
AbbVie Inc.
$112
Genentech USA, Inc.
$100
Celgene Corporation
$90
Galderma Laboratories, L.P.
$85
DUSA Pharmaceuticals, Inc.
$83
UCB, Inc.
$78
Intersect ENT, Inc.
$69
Dermavant Sciences, Inc.
$62
SUN PHARMACEUTICAL INDUSTRIES INC.
$52
GlaxoSmithKline, LLC.
$48
Merz North America, Inc.
$44
AstraZeneca Pharmaceuticals LP
$44
Almirall LLC
$30
PruGen, Inc. Pharmaceuticals
$25
Neurent Medical Limited
$23
Mayne Pharma Inc.
$22
Integra LifeSciences Corporation
$22
DERMIRA, INC.
$21
Misonix Inc
$21
Inspire Medical Systems, Inc.
$20
Helsinn Therapeutics (U.S.), Inc.
$20
Biofrontera Inc.
$19
EPI Health, LLC
$16
Entellus Medical, Inc.
$14
Journey Medical Corporation
$13
Aclaris Therapeutics, Inc.
$12
Top 3 companies account for 36.0% of all-time payments
Associated products mentioned in payments ›
ABSORICA (isotretinoin) · ACCLARENT AERA · ADBRY · AIRSUPRA · AKLIEF · Absorica LD · Ameluz · BLU-U · BLU-U Blue Light Photodynamic Therapy Illuminator Model 4170 · BRYHALI · CIBINQO · CLODERM · COSENTYX · Cimzia · DERMATITIS - DISEASE · DORYX · DUOBRII · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · ELIDEL · ENSTILAR · ENTELLUS - FIAGON SINUS NAVIGATION SYSTEM · ENTELLUS - XPRESS ENT DILATION SYSTEM · EPIDUO FORTE · EUCRISA · Enbrel · Erivedge · HUMIRA · Humira · ILUMYA · ILUMYA (tildrakizumab-asmn) injection · INSPIRE · JARDIANCE · LIBTAYO · NEUROMARK Device · NUCALA · NUVENT · ODOMZO · OLUMIANT · ONEXTON · OPZELURA · Odomzo · Otezla · PROPEL · QBREXZA · REMICADE · RETIN-A-MICRO · RHOFADE · RINVOQ · SHAVER SYSTEM · SILIQ · SKYRIZI · Seysara · Sotyktu · TALTZ · TREMFYA · Tremfya · VALCHLOR · VTAMA · XEOMIN · XPRESS ENT DILATION SYSTEM · Xhance
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Mohs-micrographic surgery physicians within 10 mi
32
Per 100K population
1.0
County median income
$113,702
Nearest hospital
UCI HEALTH - LOS ALAMITOS
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Yoo is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Yoo experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Yoo performed 874 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Yoo receive payments from pharmaceutical companies?
Yes. Dr. Yoo received a total of $7,154 from 43 companies across 263 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Yoo's costs compare to other mohs-micrographic surgery physicians in Los Alamitos?
Dr. Yoo's average Medicare payment per service is $117. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Yoo) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Mohs-Micrographic Surgery Physicians in Los Alamitos
Browse mohs-micrographic surgery physicians in Los Alamitos ranked by procedure volume and transparency data.
Highest volume
Top Mohs-Micrographic Surgery Physicians in CA
Mohs-micrographic surgery physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Mohs-Micrographic Surgery Physicians in CA
Which CA mohs-micrographic surgery physicians receive the most from drug and device companies.
By company
Stryker Corporation Payments to Doctors
See all physicians who received payments from Stryker Corporation.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology